Cargando...
Molecular landscape and targeted therapy of acute myeloid leukemia
For decades, genetic aberrations including chromosome and molecular abnormalities are important diagnostic and prognostic factors in acute myeloid leukemia (AML). ATRA and imatinib have been successfully used in AML and chronic myelogenous leukemia, which proved that targeted therapy by identifying...
Gardado en:
| Publicado en: | Biomark Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6225571/ https://ncbi.nlm.nih.gov/pubmed/30455953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-018-0146-7 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|